Vcare Mediplast Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 23-06-2024
- Paid Up Capital ₹ 1.00 M
as on 23-06-2024
- Company Age 10 Year, 10 Months
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 5.00 M
as on 23-06-2024
- Revenue 19.04%
(FY 2020)
- Profit 11.68%
(FY 2020)
- Ebitda 51.11%
(FY 2020)
- Net Worth 54.16%
(FY 2020)
- Total Assets 96.97%
(FY 2020)
About Vcare Mediplast
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹5.00 M.
Divya Jajoo, Deepti Garg, and Narayan Agrawal serve as directors at the Company.
- CIN/LLPIN
U24233MP2013PTC031905
- Company No.
031905
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Dec 2013
- Date of AGM
22 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Vcare Mediplast Private Limited offer?
Vcare Mediplast Private Limited offers a wide range of products and services, including Towels, Napkins & Handkerchieves, Aprons, Cushion & Cushion Covers, Pillow Covers, Bed Linen & Bedspreads, Bed Sheets, Medical & Surgical Clothing, OT Linen, Pharmaceutical Machinery & Equipment, Pharmaceutical Machines.
Who are the key members and board of directors at Vcare Mediplast?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Divya Jajoo  | Director | 27-Apr-2019 | Current |
| Deepti Garg | Director | 06-Dec-2013 | Current |
| Narayan Agrawal | Director | 06-Dec-2013 | Current |
Financial Performance and Corporate Structure Insights of Vcare Mediplast.
Vcare Mediplast Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 19.04% increase. The company also saw a substantial improvement in profitability, with a 11.68% increase in profit. The company's net worth Soared by an impressive increase of 54.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vcare Mediplast?
In 2020, Vcare Mediplast had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Tiaa Agrihouse Private Limited
Active
7 years 2 months Divya Jajoo, Deepti Garg and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 03 May 2017 | ₹5.00 M | Open |
How Many Employees Work at Vcare Mediplast?
Unlock and access historical data on people associated with Vcare Mediplast, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of Jan 22, 2015, Vcare Mediplast has raised a total of ₹ 0.9 M, with the most recent deal valued at ₹ 0.9 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
